Authors: Campbell, NRC Carruthers, SG Wilson, E Nagpal, S Chockalingam, A Squires, T Levine, M Zarnke, K McAlister, F Abbott, C Mann, K Bolli, P McKay, D Myers, M Wilson, T Honos, G Burgess, E Petrella, R Touyz, R Lewanczuk, R Wright, J Culleton, B Leenen, F Rabkin, S Stone, J Fodor, G Hamet, P Herman, R Lebel, M Burgess, E Tobe, S Feldman, RD Irvine, J Eady, A Nagpai, S Campbell, N Milot, A Chockalingam, A Ebenhoeh, H Drouin, D Feldman, R Repchinsky, C Ruddy, T Stewart, P Tremblay, G Wilson, E

Citation: Nrc. Campbell et al., The 2000 Canadian hypertension recommendations: A summary, CAN J CARD, 17(5), 2001, pp. 535-538

Authors: McAlister, FA Levine, M Zarnke, KB Campbell, N Lewanczuk, R Leenen, F Rabkin, S Wright, JM Stone, J Feldman, RD Lebel, M Honos, G Fodor, G Burgess, E Tobe, S Hamet, P Herman, R Irvine, J Culleton, B Petrella, R Touyz, R

Citation: Fa. Mcalister et al., The 2000 Canadian recommendations for the management of hypertension: Partone - therapy, CAN J CARD, 17(5), 2001, pp. 543-559

Authors: Berry, C Touyz, R Dominiczak, AF Webb, RC Johns, DG

Citation: C. Berry et al., Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide, AM J P-HEAR, 281(6), 2001, pp. H2337-H2365

Authors: Touyz, R

Citation: R. Touyz, Molecular and cellular mechanisms regulating vascular function and structure - Implications in the pathogenesis of hypertension (vol 16, pg 1137, 2000), CAN J CARD, 16(11), 2000, pp. 1451-1451